2022 annual financial data
Capricor Therapeutics 2022 Operating margin
Direct answer
Operating margin was -1,163.93%.
Operating income was -29,697,383 USD and net income was -29,019,532 USD.
Operating cash flow was 4,916,637 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,551,469 USD
- Operating income
- -29,697,383 USD
- Net income
- -29,019,532 USD
- Operating cash flow
- 4,916,637 USD